The cost of delaying treatment in multiple sclerosis: what is lost is not regained

Neurology. 2002 Feb 26;58(4):668; author reply 668.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Clinical Trials as Topic / economics
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / statistics & numerical data
  • Humans
  • Magnetic Resonance Imaging / economics
  • Magnetic Resonance Imaging / methods
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / economics*